Pheo Para Alliance has designated the UCLA Endocrine Center as a Center of Excellence, the first designation made on the west coast. The Center of Excellence Program recognizes institutions worldwide for providing cutting-edge, quality, multi-disciplinary care and participating in pheo and para and related research. UCLA’s announcement brings the total list of Clinical Centers and Centers of Excellence to seven, with more announcements slated throughout 2021.
Drs. Masha Livhits and Michael Yeh serve as the Pheo Para Center of Excellence Program Co-Directors. Dr. Livhits, Assistant Professor of Surgery, who oversees pheochromocytoma and paraganglioma patients during all phases of care, states, “We understand that a diagnosis of a rare but serious disease like pheochromocytoma is scary. Our team is here to guide patients throughout their entire care cycle, from initial diagnosis and surgery to long-term surveillance and dealing with complications or recurrence. Since our anesthesiologists and surgeons take care of so many patients with pheochromocytoma and paraganglioma, we can reduce the risks and make the operations much more routine.” Dr. Yeh, Professor of Surgery, adds “Our mission is to bring together expertise in endocrine surgery, medical endocrinology, oncology, pathology, ultrasound, nuclear medicine, and genetics to offer the highest level of patient care and research available.”
About UCLA Endocrine Center
UCLA is the #1 ranked hospital in California and top 3 in the nation. The UCLA Endocrine Center is a multidisciplinary integrated practice unit where physicians with diverse areas of expertise come together to provide world-class care to each patient. We have multiple satellite locations throughout Southern California with endocrinologists and endocrine surgeons working together to provide comprehensive patient care. We have embraced telemedicine even prior to the Covid-19 pandemic, and this service is particularly helpful to coordinate care for patients with complex medical issues like pheochromocytoma or paraganglioma who live at a distance from our UCLA campus.
Contact: email@example.com; 442-615-9221 re: this release